(Q33358921)

English

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

oligodendrocyte

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Roberta Rudà

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Riccardo Soffietti

1

object named as

Riccardo Soffietti

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Mauro Nobile

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Marzia Borgognone

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alessandra Costanza

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Elena Laguzzi

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Roberto Mutani

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

807-813

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Phase II trial of temozolomide in patients with progressive low-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Salvage chemotherapy with paclitaxel for recurrent oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Carboplatin: the clinical spectrum to date

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Phase II study of carboplatin in children with progressive low-grade gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Intravenous carboplatin for recurrent malignant glioma: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Treatment of adults with progressive oligodendroglioma with carboplatin (CBDCA): preliminary results. Writing Committee for The Brain Tumor Center at Duke

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Weekly dosing of carboplatin increases risk of allergy in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

21 January 2018

Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage chemotherapy for oligodendroglioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Temozolomide chemotherapy in recurrent oligodendroglioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of intravenous carboplatin for the treatment of recurrent gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to cisplatin and analogues: mechanisms and potential clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20042

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20042

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33358921&oldid=1768047939"